Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04234048 |
Title | Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | SciTech Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Southern California | RECRUITING | Los Angeles | California | 90007 | United States | Details |
University of Colorado Anschutz Medical Campus | RECRUITING | Aurora | Colorado | 80045 | United States | Details |
University of Michigan | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
Barbara Ann Karmanos Cancer Institute Wayne State University | RECRUITING | Detroit | Michigan | 48201 | United States | Details |
Columbia University | RECRUITING | New York | New York | 10032 | United States | Details |
University of Pittsburgh Medical Center (UPMC) | RECRUITING | Pittsburgh | Pennsylvania | 15219 | United States | Details |
The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |